308 related articles for article (PubMed ID: 24699704)
21. Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo.
Qian K; Huang H; Peterson A; Hu B; Maragakis NJ; Ming GL; Chen H; Zhang SC
Stem Cell Reports; 2017 Apr; 8(4):843-855. PubMed ID: 28366455
[TBL] [Abstract][Full Text] [Related]
22. Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.
Thonhoff JR; Ojeda L; Wu P
Curr Stem Cell Res Ther; 2009 Sep; 4(3):178-99. PubMed ID: 19492980
[TBL] [Abstract][Full Text] [Related]
23. Neuroimaging and clinical trials with stem cells in amyotrophic lateral sclerosis: present and future perspectives.
García Santos JM; García Martínez-Lozano M; Vázquez Olmos C; Blanquer M
Radiologia (Engl Ed); 2019; 61(3):183-190. PubMed ID: 30606510
[TBL] [Abstract][Full Text] [Related]
24. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis.
Mitrecić D; Nicaise C; Gajović S; Pochet R
Cell Transplant; 2010; 19(5):537-48. PubMed ID: 20350352
[TBL] [Abstract][Full Text] [Related]
25. The Role of Human Pluripotent Stem Cells in Amyotrophic Lateral Sclerosis: From Biological Mechanism to Practical Implications.
Ceccarelli L; Verriello L; Pauletto G; Valente M; Spadea L; Salati C; Zeppieri M; Ius T
Front Biosci (Landmark Ed); 2024 Mar; 29(3):114. PubMed ID: 38538275
[TBL] [Abstract][Full Text] [Related]
26. The past, present and future of stem cell clinical trials for ALS.
Thomsen GM; Gowing G; Svendsen S; Svendsen CN
Exp Neurol; 2014 Dec; 262 Pt B():127-37. PubMed ID: 24613827
[TBL] [Abstract][Full Text] [Related]
27. Human glial progenitor engraftment and gene expression is independent of the ALS environment.
Haidet-Phillips AM; Doreswamy A; Gross SK; Tang X; Campanelli JT; Maragakis NJ
Exp Neurol; 2015 Feb; 264():188-99. PubMed ID: 25523812
[TBL] [Abstract][Full Text] [Related]
28. Research advances in amyotrophic lateral sclerosis, 2009 to 2010.
Traub R; Mitsumoto H; Rowland LP
Curr Neurol Neurosci Rep; 2011 Feb; 11(1):67-77. PubMed ID: 21080240
[TBL] [Abstract][Full Text] [Related]
29. Stem cell transplantation for spinal cord neurodegeneration.
Lepore AC; Maragakis NJ
Methods Mol Biol; 2011; 793():479-93. PubMed ID: 21913120
[TBL] [Abstract][Full Text] [Related]
30. Stem Cell Transplantation for Amyotrophic Lateral Sclerosis.
Zhu Q; Lu P
Adv Exp Med Biol; 2020; 1266():71-97. PubMed ID: 33105496
[TBL] [Abstract][Full Text] [Related]
31. Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis.
Popescu IR; Nicaise C; Liu S; Bisch G; Knippenberg S; Daubie V; Bohl D; Pochet R
Stem Cells Transl Med; 2013 Mar; 2(3):167-74. PubMed ID: 23413376
[TBL] [Abstract][Full Text] [Related]
32. Patient-Specific Cells for Modeling and Decoding Amyotrophic Lateral Sclerosis: Advances and Challenges.
Zhao A; Pan Y; Cai S
Stem Cell Rev Rep; 2020 Jun; 16(3):482-502. PubMed ID: 31916190
[TBL] [Abstract][Full Text] [Related]
33. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
[TBL] [Abstract][Full Text] [Related]
34. iPSC-derived LewisX+CXCR4+β1-integrin+ neural stem cells improve the amyotrophic lateral sclerosis phenotype by preserving motor neurons and muscle innervation in human and rodent models.
Nizzardo M; Bucchia M; Ramirez A; Trombetta E; Bresolin N; Comi GP; Corti S
Hum Mol Genet; 2016 Aug; 25(15):3152-3163. PubMed ID: 27270413
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of stem cell therapies in amyotrophic lateral sclerosis.
Srivastava AK
Neurol India; 2014; 62(3):239-48. PubMed ID: 25033844
[TBL] [Abstract][Full Text] [Related]
36. Translational stem cell therapy for amyotrophic lateral sclerosis.
Boulis NM; Federici T; Glass JD; Lunn JS; Sakowski SA; Feldman EL
Nat Rev Neurol; 2011 Dec; 8(3):172-6. PubMed ID: 22158518
[TBL] [Abstract][Full Text] [Related]
37. Modelling and treating amyotrophic lateral sclerosis through induced-pluripotent stem cells technology.
Bohl D; Pochet R; Mitrecic D; Nicaise C
Curr Stem Cell Res Ther; 2016; 11(4):301-12. PubMed ID: 26018231
[TBL] [Abstract][Full Text] [Related]
38. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
[TBL] [Abstract][Full Text] [Related]
39. Intraspinal injection of human umbilical cord blood-derived cells is neuroprotective in a transgenic mouse model of amyotrophic lateral sclerosis.
Knippenberg S; Thau N; Schwabe K; Dengler R; Schambach A; Hass R; Petri S
Neurodegener Dis; 2012; 9(3):107-20. PubMed ID: 22122965
[TBL] [Abstract][Full Text] [Related]
40. Transplantation of mesenchymal stem cells in ALS.
Mazzini L; Vercelli A; Ferrero I; Boido M; Cantello R; Fagioli F
Prog Brain Res; 2012; 201():333-59. PubMed ID: 23186722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
